FDA Application
-
NDC Search Results on Active Ingredient: acetaminophen
Click on Active Ingredient to view the label.
Ingredient Name | NDC | Company Name | Application Number or Regulatory Citation | Product Type | Marketing Category |
---|---|---|---|---|---|
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE; ACETAMINOPHEN | 37808-708-26 | H E B | part341 | HUMAN OTC DRUG | OTC monograph final |
PHENYLEPHRINE HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE; ACETAMINOPHEN | 37808-718-83 | H E B | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN | 37808-747-71 | H E B | ANDA075077 | HUMAN OTC DRUG | ANDA |
ACETAMINOPHEN | 37808-759-26 | H E B | part343 | HUMAN OTC DRUG | OTC monograph not final |
PHENYLEPHRINE HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; ACETAMINOPHEN | 37808-763-40 | H E B | part341 | HUMAN OTC DRUG | OTC monograph final |
GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE; ACETAMINOPHEN | 37808-775-02 | HEB | part341 | HUMAN OTC DRUG | OTC monograph final |
ACETAMINOPHEN | 37808-792-01 | HEB | part343 | HUMAN OTC DRUG | OTC monograph not final |
ACETAMINOPHEN | 37808-792-03 | HEB | part343 | HUMAN OTC DRUG | OTC monograph not final |
DIPHENHYDRAMINE HYDROCHLORIDE; ACETAMINOPHEN | 37808-795-03 | HEB | part341 | HUMAN OTC DRUG | OTC monograph final |
GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE; ACETAMINOPHEN | 37808-796-40 | H E B | part341 | HUMAN OTC DRUG | OTC monograph final |
ACETAMINOPHEN; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE; DEXTROMETHORPHAN HYDROBROMIDE | 37808-811-40 | H E B | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE | 37808-848-16 | H E B | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE | 37808-864-16 | H E B | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN | 37808-945-08 | H E B | M013 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN | 37808-946-16 | H E B | part343 | HUMAN OTC DRUG | OTC monograph not final |
DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE; ACETAMINOPHEN | 37808-971-16 | H E B | part341 | HUMAN OTC DRUG | OTC monograph final |
ACETAMINOPHEN | 37808-980-62 | H E B | part343 | HUMAN OTC DRUG | OTC monograph not final |
ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE | 37808-994-60 | H E B | part341 | HUMAN OTC DRUG | OTC monograph final |
ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE | 37808-994-62 | H E B | part341 | HUMAN OTC DRUG | OTC monograph final |
ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE | 37835-524-02 | Bi-Mart | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; DOXYLAMINE SUCCINATE | 37835-524-30 | Bi-Mart | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE; ACETAMINOPHEN | 37835-526-02 | Bi-Mart | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE; ACETAMINOPHEN | 37835-526-30 | Bi-Mart | M012 | HUMAN OTC DRUG | OTC Monograph Drug |
ACETAMINOPHEN; HYDROCODONE BITARTRATE | 40032-351-01 | Novel Laboratories, Inc. | ANDA206142 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; HYDROCODONE BITARTRATE | 40032-351-03 | Novel Laboratories, Inc. | ANDA206142 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; HYDROCODONE BITARTRATE | 40032-351-05 | Novel Laboratories, Inc. | ANDA206142 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; HYDROCODONE BITARTRATE | 40032-352-01 | Novel Laboratories, Inc. | ANDA206142 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; HYDROCODONE BITARTRATE | 40032-352-03 | Novel Laboratories, Inc. | ANDA206142 | HUMAN PRESCRIPTION DRUG | ANDA |
ACETAMINOPHEN; HYDROCODONE BITARTRATE | 40032-352-05 | Novel Laboratories, Inc. | ANDA206142 | HUMAN PRESCRIPTION DRUG | ANDA |
HYDROCODONE BITARTRATE; ACETAMINOPHEN | 40032-353-01 | Novel Laboratories, Inc. | ANDA206142 | HUMAN PRESCRIPTION DRUG | ANDA |
-